NAOV Key Statistics, Chart & Performance
The current stock price of NAOV is 4.02 USD. In the past month the price decreased by -16.08%. In the past year, price decreased by -99.41%.
NAOV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.02 | 217.08B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.11 | 204.83B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.56 | 142.40B | ||
| SYK | STRYKER CORP | 26.9 | 135.46B | ||
| BDX | BECTON DICKINSON AND CO | 13.62 | 56.04B | ||
| IDXX | IDEXX LABORATORIES INC | 54.6 | 54.98B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.79 | 50.40B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.22 | 38.09B | ||
| RMD | RESMED INC | 24.72 | 35.73B | ||
| DXCM | DEXCOM INC | 36.33 | 26.35B | ||
| PODD | INSULET CORP | 63.16 | 20.31B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.22 | 17.99B |
Related stock screener links
About NAOV
Company Profile
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. The firm focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure.
Company Info
NANOVIBRONIX INC
969 Pruitt Piace
Tyler TEXAS 10523 US
CEO: Brian Murphy
Employees: 31
Phone: 19142333004
NANOVIBRONIX INC / NAOV FAQ
What does NANOVIBRONIX INC do?
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. The firm focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure.
What is the stock price of NANOVIBRONIX INC today?
The current stock price of NAOV is 4.02 USD. The price decreased by -6.73% in the last trading session.
What is the dividend status of NANOVIBRONIX INC?
NAOV does not pay a dividend.
What is the ChartMill technical and fundamental rating of NAOV stock?
NAOV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
On which exchange is NAOV stock listed?
NAOV stock is listed on the Nasdaq exchange.
What is NANOVIBRONIX INC worth?
NANOVIBRONIX INC (NAOV) has a market capitalization of 4.38M USD. This makes NAOV a Nano Cap stock.
What is the next earnings date for NAOV stock?
NANOVIBRONIX INC (NAOV) will report earnings on 2026-03-30.
NAOV Technical Analysis
NAOV Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NAOV. Both the profitability and financial health of NAOV have multiple concerns.
NAOV Financial Highlights
Over the last trailing twelve months NAOV reported a non-GAAP Earnings per Share(EPS) of -83.93. The EPS increased by 39.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.54% | ||
| ROE | -13.4% | ||
| Debt/Equity | 0.05 |